Everence Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$721K Sell
4,043
-37
-0.9% -$6.05K 0.04% 313
2026
Q2
$612K Hold
4,080
– – 0.03% 358
2026
Q1
$377K Hold
4,080
– – 0.02% 474
2025
Q4
$417K Hold
4,080
– – 0.02% 453
2025
Q3
$255K Hold
4,080
– – 0.02% 674
2025
Q2
$212K Buy
+4,080
New +$182K 0.01% 734

Other funds holding GH

Everence Capital Management's GH Position: Q3 2026 in Review

Everence Capital Management reduced its Guardant Health (GH) stake by 0.91% in Q3 2026, selling an estimated $6.05K and leaving 4,043 shares worth $721K. The position accounts for 0.04% of the portfolio, ranked #313.

Everence Capital Management first reported a position in GH in Q2 2025 and has held it in 6 quarters since. 676 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Everence Capital Management held 4,043 shares of Guardant Health worth $721K as of Q3 2026.
  • Everence Capital Management sold 37 Guardant Health shares in Q3 2026, an estimated $6.05K.
  • Guardant Health made up 0.04% of Everence Capital Management's portfolio in Q3 2026, its #313 holding.
  • Everence Capital Management first reported a position in Guardant Health in Q2 2025 and has held it in 6 quarters since.
  • 676 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.